Presentation One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study Presenter: Zuzana Motovska November 11, 2017 REGISTER for free or LOG IN to view this content Coronary ACS/AMI CAD Pharma Presentation AHA 2017 Up Next Presentation Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial Presenter: Akihiko Nogami November 13, 2017 More slides + Presentation Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial Presenter: Steven Weisbord November 13, 2017 Presentation Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes Presenter: Louise Bowman November 14, 2017 We Recommend
Presentation Clinical Benefit of Minimally-Interrupted Dabigatran versus Uninterrupted Warfarin for Catheter Ablation of Atrial Fibrillation: A Prospective Randomized Multicenter Trial Presenter: Akihiko Nogami November 13, 2017
Presentation Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial Presenter: Steven Weisbord November 13, 2017
Presentation Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes Presenter: Louise Bowman November 14, 2017